Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Primary hyperaldosteronism
ADR ID BADD_A07599
ADR Hierarchy
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.04      Endocrine and metabolic secondary hypertension
24.08.04.006      Primary hyperaldosteronism
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.01      Adrenal cortical hyperfunctions
05.01.01.007      Primary hyperaldosteronism
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.04      Sodium imbalance
14.05.04.010      Primary hyperaldosteronism
Description A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. | Primary hyperaldosteronism caused by the excess production of ALDOSTERONE by an ADENOMA of the ZONA GLOMERULOSA or CONN ADENOMA. [MeSH]
MedDRA Code 10036692
MeSH ID D006929
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Conn's syndrome | Primary hyperaldosteronism | Hyperaldosteronism | Aldosteronism | Conn Syndrome | Syndrome, Conn | Primary Hyperaldosteronism | Hyperaldosteronism, Primary | Conn's Syndrome | Conns Syndrome | Syndrome, Conn's
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00085Alprazolam0.000029%
BADD_D02147Telmisartan0.000260%
The 1th Page    1    Total 1 Pages